The George Institute For Global Health
Global
United Kingdom
India
China
Australia

Publications

Found 8137 results
2019
Lung T, Marks G, Nhung N, et al. Household contact investigation for the detection of tuberculosis in Vietnam: economic evaluation of a cluster-randomised trial. The Lancet Global Health. 2019;7:e376 - e384. doi:10.1016/S2214-109X(18)30520-5.
Jun M, Jardine M, Perkovic V, et al. Hyperkalemia and renin-angiotensin aldosterone system inhibitor therapy in chronic kidney disease: A general practice-based, observational study. PLoS One. 2019;14:e0213192. doi:10.1371/journal.pone.0213192.
Jun M, Jardine M, Perkovic V, et al. Hyperkalemia and renin-angiotensin aldosterone system inhibitor therapy in chronic kidney disease: A general practice-based, observational study. PLoS ONE. 2019;14. doi:10.1371/journal.pone.0213192.
Sriravindrarajah A, Kotwal S, Sen S, et al. Impact of Supplemental Private Health Insurance on Dialysis and Outcomes. Intern Med J. 2019. doi:10.1111/imj.14375.
Peng K, Tian M, Andersen M, et al. Incidence, risk factors and economic burden of fall-related injuries in older Chinese people: A systematic review. Injury Prevention. 2019;25:4 - 12. doi:10.1136/injuryprev-2018-042982.
Chen R, Wang X, Anderson C, et al. Infratentorial Intracerebral Hemorrhage. Stroke. 2019;50:1257 - 1259. doi:10.1161/STROKEAHA.118.023766.
Ramachandran R, Jha V. Integration with kidney disease improving global outcomes (KDIGO). In: Glomerulonephritis. Glomerulonephritis.; 2019:87 - 95. doi:10.1007/978-3-319-49379-4_6.
Anderson C, Huang Y, Lindley R, et al. Intensive blood pressure reduction with intravenous thrombolysis therapy for acute ischaemic stroke (ENCHANTED): an international, randomised, open-label, blinded-endpoint, phase 3 trial. The Lancet. 2019;393:877 - 888. doi:10.1016/S0140-6736(19)30038-8.
Anderson C, Huang Y, Lindley R, et al. Intensive blood pressure reduction with intravenous thrombolysis therapy for acute ischaemic stroke (ENCHANTED): an international, randomised, open-label, blinded-endpoint, phase 3 trial. Lancet. 2019. doi:10.1016/S0140-6736(19)30038-8.
Santos J, Christoforou A, Trieu K, et al. Iodine fortification of foods and condiments, other than salt, for preventing iodine deficiency disorders. Cochrane Database of Systematic Reviews. 2019;2019. doi:10.1002/14651858.CD010734.pub2.
Ramachandran R, Nayak S, Anakutti H, et al. Is Postpartum Renal Cortical Necrosis in Developing Countries Due to Atypical Hemolytic Uremic Syndrome?. Kidney International Reports. 2019. doi:10.1016/j.ekir.2018.11.012.
Redfern J, Hyun K, Singleton A, et al. ITM support for patients with chronic respiratory and cardiovascular diseases: A protocol for a randomised controlled trial. BMJ Open. 2019;9. doi:10.1136/bmjopen-2018-023863.
Kapoor D, Gupta Y, Desai A, et al. Lifestyle intervention programme for Indian women with history of gestational diabetes mellitus. Global Health, Epidemiology and Genomics. 2019;4. doi:10.1017/gheg.2018.18.
McGuire D, Alexander J, Johansen O, et al. Linagliptin Effects on Heart Failure and Related Outcomes in Individuals With Type 2 Diabetes Mellitus at High Cardiovascular and Renal Risk in CARMELINA. Circulation. 2019;139:351 - 361. doi:10.1161/CIRCULATIONAHA.118.038352.
Maulik P, Devarapalli S, Kallakuri S, Tripathi A, Koschorke M, Thornicroft G. Longitudinal assessment of an anti-stigma campaign related to common mental disorders in rural India. British Journal of Psychiatry. 2019;214:90 - 95. doi:10.1192/bjp.2018.190.
Jan S. Making sense of paying for performance in health care: Short-term targets versus patient-relevant outcomes. Australian Health Review. 2019. doi:10.1071/AH18178.
Jan S. Making sense of paying for performance in health care: short-term targets versus patient-relevant outcomes. Australian health review : a publication of the Australian Hospital Association. 2019. doi:10.1071/ah18178.
Jan S. Making sense of paying for performance in health care: short-term targets versus patient-relevant outcomes. Aust Health Rev. 2019. doi:10.1071/AH18178.
Floege J, Barbour S, Cattran D, et al. Management and treatment of glomerular diseases (part 1): conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference. In: Kidney International; 2019:268 - 280. doi:10.1016/j.kint.2018.10.018.
Rovin B, Caster D, Cattran D, et al. Management and treatment of glomerular diseases (part 2): conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference. In: Kidney International; 2019:281 - 295. doi:10.1016/j.kint.2018.11.008.
Kilkenny M, Kim J, Andrew N, et al. Maximising data value and avoiding data waste: a validation study in stroke research. The Medical journal of Australia. 2019;210:27 - 31. doi:10.5694/mja2.12029.
Küpers L, Monnereau C, Sharp G, et al. Meta-analysis of epigenome-wide association studies in neonates reveals widespread differential DNA methylation associated with birthweight. Nature Communications. 2019;10. doi:10.1038/s41467-019-09671-3.